TOP TIERMARKET NEWSWIRE
News & sentiment

MEDLINE INC Class A (MDLN) — News & AI sentiment

MEDLINE INC Class A (MDLN) news roundup. 1 story in the last 24 hours, 7 in the past week, 35 over 30 days. Average 24-hour sentiment is 34/100 — bearish-leaning (50 is neutral). Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 5 sales totalling $1.2B — net selling of $1.2B. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
1
avg sentiment 34/100
7d stories
7
avg sentiment 43.6/100
30d stories
35
avg sentiment 41.7/100
Insider net (90d)
$1.2B
0 buys · 5 sells
Congress (90d)
0
0 buys · 0 sells

MDLN news in the last 24 hours, 7 days, 30 days and 90 days

How much MDLN coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowMDLN storiesAvg AI sentimentRead
Last 24 hours134/100MDLN headlines →
Last 7 days743.6/100MDLN headlines →
Last 30 days3541.7/100MDLN headlines →
Last 90 days8542.9/100MDLN headlines →

Latest stories on MDLN

5h ago
2d ago
2d ago
5d ago
5d ago
Medline Exits Market for Front Line Care Beds
TipRanks42 · neutralproduct/pr
7d ago
Medline Inc. (MDLN) files 8-K
SEC 8-K50 · neutralgeneral
7d ago
Oct 21
Oct 19
Oct 16
Medline Inc.: Beware The Private Equity Overhang
Seeking Alpha42 · neutralanalyst
Oct 16
Oct 16
Medline Inc. (MDLN) files 8-K
SEC 8-K50 · neutralgeneral
Oct 15
Oct 15
Oct 15
Oct 13
Oct 13
Oct 12
Oct 12
Oct 9
Oct 9
Oct 8
Oct 7
Oct 7
Oct 6
Open MDLN in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →